Celularity - Class A (CELU) closed at $0.71 on November 10, 2026, down 6.4% from the previous close, on volume of 100,018 shares (30-day average 151,756).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Covered Put | 20-Nov-26 1.5 P +89,200 Stock | 892 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
Business Wire (Thu, 29-Oct 9:00 AM ET)
Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
Globe Newswire (Thu, 22-Oct 8:00 AM ET)
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
Globe Newswire (Wed, 30-Sep 11:57 AM ET)
Celularity Announces Naveen Jain to Join Board of Directors
Globe Newswire (Tue, 29-Sep 8:30 AM ET)
Globe Newswire (Thu, 24-Sep 9:15 AM ET)
Business Wire (Thu, 27-Aug 9:00 AM ET)
Celularity Provides Update Regarding Nasdaq Listing Compliance
Globe Newswire (Tue, 25-Aug 7:59 PM ET)
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Celularity - Class A trades on the NASDAQ stock market under the symbol CELU.
As of November 11, 2026, CELU stock price climbed to $0.77 with 41,843 million shares trading.
CELU has a beta of 1.97, meaning it tends to be more sensitive to market movements. CELU has a correlation of 0.05 to the broad based SPY ETF.
CELU has a market cap of $24.99 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELU traded as high as $7.97 and as low as $.56.
The top ETF exchange traded funds that CELU belongs to (by Net Assets): VTI, VXF.
CELU has underperformed the market in the last year with a price return of -56.5% while the SPY ETF gained +12.7%. However, in the short term, CELU had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.1% vs -1.4% return in SPY. But in the last 2 weeks, CELU shares have been beat by the market, returning -2.6% compared to an SPY return of -1.2%.
CELU support price is $.64 and resistance is $.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELU shares will trade within this expected range on the day.
